Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes [Phase 4]
Phase 4 clinical trial update on dual-hormone closed-loop glucose control for Type 1 diabetes, with consideration of hypoglycemia outcomes.
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 Diabetes [Phase 4]
Phase 4 clinical trial update on dual-hormone closed-loop glucose control in adolescents with type 1 diabetes.
-
EMA withdrawal · 2022-08-16EMA Withdrawn: Zynquista (sotagliflozin) — Guidehouse Germany GmbH
The EMA withdrew Zynquista (sotagliflozin) from development/marketing for Type 1 diabetes, with Guidehouse Germany GmbH as the MAH, decision…
-
FDA approval · 2022-08-16FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for TOUJEO (insulin glargine) from Sanofi-Aventis U.S. LLC, resulting in updated labeling for th…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Effect of Live Combined Bifidobacterium and Lactobacillus on Glycemic Control and Other Outcomes in Type 1 Diabetes [Phase 4]
Phase 4 trial assessing the effect of live combined Bifidobacterium and Lactobacillus on glycemic control and other outcomes in type 1 diabe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Pharmacokinetics (PK)/ Pharmacodynamics (PD) of an Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Patients ("PEXIS") [NA]
A completed clinical trial evaluating pharmacokinetics and pharmacodynamics of an extended wear subcutaneous insulin infusion set in adults …
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes [Phase 2]
A Phase 2 crossover trial evaluating postprandial glucose after a mixed meal tolerance test and metabolic effects of insulin withdrawal in a…
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes [NA]
Clinical trial comparing a sensor-augmented insulin pump to multiple daily injections using degludec as basal insulin in adults with Type 1 …
-
CLINICAL_TRIALS research · 2022-07-15Clinical Trial Update: Metabolic Pathways of GRA in Patients With Type 1 Diabetes [Phase 1, Phase 2]
Clinical trial update describing metabolic pathways of GRA in patients with Type 1 Diabetes, across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes [Phase 2]
Phase 2 trial evaluating the anti-TNF agent golimumab (SIMPONI) to arrest beta-cell loss in Type 1 diabetes; the study has completed and res…
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Transdisciplinary Versus Usual Care for Type1 Diabetes in Adolescence [NA]
A completed clinical trial comparing transdisciplinary care to usual care for adolescents with Type 1 diabetes; results posted in 2022.
-
FDA approval · 2022-07-01FDA Approved: TRESIBA — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for TRESIBA (insulin degludec) by Novo Nordisk.
-
FDA label_change · 2022-07-01FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approves a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk. The action updates the product labeling.
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Effects of Micronutrient (Chromium) Supplementation on Diabetes [NA]
A completed clinical trial evaluating chromium micronutrient supplementation in type 1 diabetes; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM) [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of M1 Pram P037 Prandial Insulin in adults with Type 1 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes [Phase 3]
A health economic analysis related to islet cell transplantation for stabilizing severe Type 1 Diabetes in a Phase 3 study.
-
FDA approval · 2022-06-07FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) from Sanofi-Aventis U.S. LLC, authorizing changes to the …
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting [Phase 3]
Phase 3 trial evaluating SGLT2 inhibitors with an artificial pancreas to improve glycemic control in outpatients with type 1 diabetes; study…
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes [Phase 2]
A Phase 2 clinical trial evaluating LY900014 in combination with insulin degludec in participants with Type 1 Diabetes has completed with po…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes [Phase 2]
Phase 2 trial comparing once-daily vs three-times-daily dosing of ORMD-0801 in adults with Type 1 Diabetes has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones. [Phase 4]
Phase 4 trial comparing insulin degludec with insulin glargine U100 in adults with type 1 diabetes across multiple time zones.
-
CLINICAL_TRIALS trial_result · 2022-05-26Clinical Trial Update: Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes [Phase 2]
Phase 2 clinical trial investigating desferal administration to improve impaired reaction to hypoxia in type 1 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Aralast NP in Islet Transplant [Phase 1, Phase 2]
Phase 1/2 trial update for Aralast NP in islet transplantation for Type 1 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Early High-Dose Vitamin D and Residual β-Cell Function in Pediatric Type 1 Diabetes [Phase 3]
Phase 3 trial investigating early high-dose vitamin D and residual beta-cell function in pediatric Type 1 Diabetes.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy [Phase 2]
Phase 2 clinical trial update for SB-509 in diabetic neuropathy has completed enrollment and status is completed.